Larvol Delta - 23andMe-Initiates-Phase-1-Clinical-Trial-for-First-WhollyOwned-Immunooncology-Antibody-for-Patients-with-Solid-Tumors

23ME-00610 - 23andMe

https://www.globenewswire.com/news-release/2022/01/06/2362526/0/en/23andMe-Initiates-Phase-1-Clinical-Trial-for-First-Wholly-Owned-Immuno-oncology-Antibody-for-Patients-with-Solid-Tumors.html

Jan 6, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next